All Blogs

Nov 10, 2020

Pfizer's COVID-19 vaccine heralded as the showstopper with over 90% effectiveness  Based on the interim data from the Phase III COVID-19 vaccine trial results, the pharma titan, Pfizer, announced that its COVID-19 vaccine is more than 90% effective in preventing coronavirus infection. Tedros Adhanom Ghebrey...

Nov 09, 2020

Rare renal disorders are the fifth most prominent reason behind the cause of end-stage kidney disease (ESKD), ultimately leading to kidney failure, and damage to other tissues.  Among such rare kidney diseases, one is complement 3 glomerulopathy (C3G). Albeit rare, the total diagnosed C3G prevalent population ...

Nov 06, 2020

With the onset of the era of technological advancements, it was presumed that numerous challenges, mostly toward the treatment of rare genetic disorders, would be countered. However, the quest for the appropriate treatment continues as one of the rare disorders, Argininosuccinic aciduria (ASA), remains to lack spec...

Nov 05, 2020

FDA nods Boston Scientific's paclitaxel-coated Ranger balloon for peripheral artery disease Boston Scientific has received the FDA approval for its Ranger paclitaxel-coated balloon, designed to restrict a patient's systemic exposure to the chemotherapy used to reduce the closure of reopened arteries. The slim...

Nov 04, 2020

Bristol Myers' Experimental Psoriasis drug succeeds in late-stage study defeats rival Amgen's Otezla Bristol Myers' experimental psoriasis drug, deucravacitinib has outmarched Amgen's Otezla (apremilast) in the POETYK PSO-1 Phase III clinical trial in patients with moderate to severe plaque psoriasis. Deucravaci...

Nov 03, 2020

The United States of America is undergoing the 59th quadrennial presidential election. Since the founding of the nation, the political system in the US is majorly dominated by two parties- the Democratic and the Republican party. After various campaigns and two rounds of debates between the leading presidential can...

Nov 02, 2020

Epidermolysis bullosa (EB) places a significant socioeconomic burden on patients. Several reports stated that Epidermolysis bullosa had a considerable negative impact on the quality of the lives of patients. Although it is a rare disease, EB is a cause of significant morbidity and mortality among the affected indiv...

Oct 30, 2020

Everyone can think that extra add-ons to the living may change the lifestyles. Is the leverage similar in life with an extra-chromosome?? The answer is, No! Take the case of Down syndrome (DS) that has an extra copy of chromosome 21 and associated higher societal costs with physical changes and intellectual disa...

Oct 29, 2020

Novartis taps Molecular Partners for a novel approach to combat COVID-19 Novartis is spending USD 69 million upfront on a pair of experimental drugs from Molecular Partners. The pact is for MP0420 and MP0423, two antivirals out of the biotech’s so-called DARPin tech, which Molecular Partners says that it has ...

Oct 28, 2020

Artificial intelligence (AI) is the talk of the town. Though the term AI and its uses are not new, however, in the past few years there has been a phenomenal growth in AI research and its applications. Today, AI is making its way in almost every sector. Feeding on a large amount of data, AI can mimic human-like tas...